Handout on Health
Rheumatoid
Arthritis
This is a publication of
the
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and
Skin Diseases
This booklet is not
copyrighted. Readers are encouraged to duplicate and
distribute as many copies as needed.
Additional copies of this
booklet are available from the National Arthritis and
Musculoskeletal and Skin Diseases Information
Clearinghouse, NIAMS, National Institutes of Health,
1 AMS Circle, Bethesda, Maryland 20892-3675,
and on the NIAMS Web site at http://www.nih.gov/niams/healthinfo/.
January 1998
Rheumatoid Arthritis
This booklet is for people who have rheumatoid arthritis,
as well as for their family members, friends, and others
who want to find out more about this disease. The booklet
describes how rheumatoid arthritis develops, how it is
diagnosed, and how it is treated, including what patients
can do to help manage their disease. It also highlights
current research efforts supported by the National
Institute of Arthritis and Musculoskeletal and Skin
Diseases (NIAMS) and other components of the National
Institutes of Health (NIH). If you have further questions
after reading this booklet, you may wish to discuss them
with your doctor.
Features Of Rheumatoid
Arthritis
Rheumatoid arthritis is an inflammatory disease that
causes pain, swelling, stiffness, and loss of function in
the joints. It has several special features that make it
different from other kinds of arthritis. For example,
rheumatoid arthritis generally occurs in a symmetrical
pattern. This means that if one knee or hand is involved,
the other one is also. The disease often affects the
wrist joints and the finger joints closest to the hand.
It can also affect other parts of the body besides the
joints. In addition, people with the disease may have
fatigue, occasional fever, and a general sense of not
feeling well (malaise).
Another feature of
rheumatoid arthritis is that it varies a lot from person
to person. For some people, it lasts only a few months or
a year or two and goes away without causing any
noticeable damage. Other people have mild or moderate
disease, with periods of worsening symptoms, called
flares, and periods in which they feel better, called
remissions. Still others have severe disease that is
active most of the time, lasts for many years, and leads
to serious joint damage and disability.
Although rheumatoid
arthritis can have serious effects on a person's life and
well-being, current treatment strategies-including pain
relief and other medications, a balance between rest and
exercise, and patient education and support
programs-allow most people with the disease to lead
active and productive lives. In recent years, research
has led to a new understanding of rheumatoid arthritis
and has increased the likelihood that, in time,
researchers can find ways to greatly reduce the impact of
this disease.
Features
of Rheumatoid Arthritis
- Tender, warm,
swollen joints.
- Symmetrical
pattern. For example, if one knee is
affected, the other one is also.
- Joint
inflammation often affecting the wrist
and finger joints closest to the hand;
other affected joints can include those
of the neck, shoulders, elbows, hips,
knees, ankles, and feet.
- Fatigue,
occasional fever, a general sense of not
feeling well (malaise).
- Pain and
stiffness lasting for more than 30
minutes in the morning or after a long
rest.
- Symptoms that
can last for many years.
- Symptoms in
other parts of the body besides the
joints.
- Variability
of symptoms among people with the
disease.
|
How Rheumatoid
Arthritis Develops And Progresses
The Joints
A normal joint (the place where two bones meet) is
surrounded by a joint capsule that protects and supports
it (see illustration). Cartilage covers and cushions the
ends of the two bones. The joint capsule is lined with a
type of tissue called synovium, which produces synovial
fluid. This clear fluid lubricates and nourishes the
cartilage and bones inside the joint capsule.
In rheumatoid arthritis,
the immune system, for unknown reasons, attacks a
person's own cells inside the joint capsule. White blood
cells that are part of the normal immune system travel to
the synovium and cause a reaction. This reaction, or
inflammation, is called synovitis, and it results in the
warmth, redness, swelling, and pain that are typical
symptoms of rheumatoid arthritis. During the inflammation
process, the cells of the synovium grow and divide
abnormally, making the normally thin synovium thick and
resulting in a joint that is swollen and puffy to the
touch (see illustration).
As rheumatoid arthritis
progresses, these abnormal synovial cells begin to invade
and destroy the cartilage and bone within the joint. The
surrounding muscles, ligaments, and tendons that support
and stabilize the joint become weak and unable to work
normally. All of these effects lead to the pain and
deformities often seen in rheumatoid arthritis. Doctors
studying rheumatoid arthritis now believe that damage to
bones begins during the first year or two that a person
has the disease. This is one reason early diagnosis and
treatment are so important in the management of
rheumatoid arthritis.

Other Parts of the
Body
Some people also experience the effects of rheumatoid
arthritis in places other than the joints. About
one-quarter develop rheumatoid nodules. These are bumps
under the skin that often form close to the joints. Many
people with rheumatoid arthritis develop anemia, or a
decrease in the normal number of red blood cells. Other
effects, which occur less often, include neck pain and
dry eyes and mouth. Very rarely, people may have
inflammation of the blood vessels, the lining of the
lungs, or the sac enclosing the heart.
Occurrence And Impact
Of Rheumatoid Arthritis
Scientists estimate that about 2.1 million people, or 1
percent of the U.S. adult population, have rheumatoid
arthritis. Interestingly, some recent studies have
suggested that the overall number of new cases of
rheumatoid arthritis may actually be going down.
Scientists are now investigating why this may be
happening.
Rheumatoid arthritis
occurs in all races and ethnic groups. Although the
disease often begins in middle age and occurs with
increased frequency in older people, children and young
adults also develop it. Like some other forms of
arthritis, rheumatoid arthritis occurs much more
frequently in women than in men. About two to three times
as many women as men have the disease.
By all measures, the
financial and social impact of all types of arthritis,
including rheumatoid arthritis, is substantial, both for
the Nation and for individuals. From an economic
standpoint, the medical and surgical treatment for
rheumatoid arthritis and the wages lost because of
disability caused by the disease add up to millions of
dollars. Daily joint pain is an inevitable consequence of
the disease, and most patients also experience some
degree of depression, anxiety, and feelings of
helplessness. In some cases, rheumatoid arthritis can
interfere with a person's ability to carry out normal
daily activities, limit job opportunities, or disrupt the
joys and responsibilities of family life. However, there
are arthritis self-management programs that help people
cope with the pain and other effects of the disease and
help them lead independent and productive lives. These
programs are described later in this booklet in the
section Diagnosing and Treating Rheumatoid Arthritis.
Searching For The Cause
Of Rheumatoid Arthritis
Rheumatoid arthritis is one of several
"autoimmune" diseases ("auto" means
self), so-called because a person's immune system attacks
his or her own body tissues. Scientists still do not know
exactly what causes this to happen, but research over the
last few years has begun to unravel the factors involved.
Genetic (inherited)
factors: Scientists have found that certain genes
that play a role in the immune system are associated with
a tendency to develop rheumatoid arthritis. At the same
time, some people with rheumatoid arthritis do not have
these particular genes, and other people have these genes
but never develop the disease. This suggests that a
person's genetic makeup is an important part of the story
but not the whole answer. It is clear, however, that more
than one gene is involved in determining whether a person
develops rheumatoid arthritis and, if so, how severe the
disease will become.
Environmental
factors: Many scientists think that
something must occur to trigger the disease process in
people whose genetic makeup makes them susceptible to
rheumatoid arthritis. An infectious agent such as a virus
or bacterium appears likely, but the exact agent is not
yet known. Note, however, that rheumatoid arthritis is
not contagious: A person cannot "catch" it from
someone else.
Other factors:
Some scientists also think that a variety of hormonal
factors may be involved. These hormones, or possibly
deficiencies or changes in certain hormones, may promote
the development of rheumatoid arthritis in a genetically
susceptible person who has been exposed to a triggering
agent from the environment.
Even though all the
answers aren't known, one thing is certain: Rheumatoid
arthritis develops as a result of an interaction of many
factors. Much research is going on now to understand
these factors and how they work together (see the Current
Research section of this booklet).
Diagnosing And Treating
Rheumatoid Arthritis
Diagnosing and treating rheumatoid arthritis is a team
effort between the patient and several types of health
care professionals. A person can go to his or her family
doctor or internist or to a rheumatologist. A
rheumatologist is a doctor who specializes in arthritis
and other diseases of the joints, bones, and muscles. As
treatment progresses, other professionals often help.
These may include nurses, physical or occupational
therapists, orthopedic surgeons, psychologists, and
social workers.
Studies have shown that
people who are well informed and participate actively in
their own care experience less pain and make fewer visits
to the doctor than do other people with rheumatoid
arthritis.
Patient education and
arthritis self-management programs, as well as support
groups, help people to become better informed and to
participate in their own care. An example of a
self-management program is the arthritis self-help course
offered by the Arthritis Foundation and developed at one
of the NIAMS-supported Multipurpose Arthritis and
Musculoskeletal Diseases Centers. Self-management
programs teach about rheumatoid arthritis and its
treatments, exercise and relaxation approaches,
patient/health care provider communication, and problem
solving. Research on these programs has shown that they
have the following clear and long-lasting benefits:
- They help people
understand the disease.
- They help people
reduce their pain while remaining active.
- They help people cope
physically, emotionally, and mentally.
- They help people feel
greater control over their disease and help build
a sense of confidence in the ability to function
and lead a full, active, and independent life.
DIAGNOSIS
Rheumatoid arthritis can be difficult to diagnose in its
early stages for several reasons. First, there is no
single test for the disease. In addition, symptoms differ
from person to person and can be more severe in some
people than in others. Also, symptoms can be similar to
those of other types of arthritis and joint conditions,
and it may take some time for other conditions to be
ruled out as possible diagnoses. Finally, the full range
of symptoms develops over time, and only a few symptoms
may be present in the early stages. As a result, doctors
use a variety of tools to diagnose the disease and to
rule out other conditions:
Medical history: This
is the patient's description of symptoms and when and how
they began. Good communication between patient and doctor
is especially important here. For example, the patient's
description of pain, stiffness, and joint function and
how these change over time is critical to the doctor's
initial assessment of the disease and his or her
assessment of how the disease changes.
Physical
examination: This includes the doctor's
examination of the joints, skin, reflexes, and muscle
strength.
Laboratory tests:
One common test is for rheumatoid factor, an antibody
that is eventually present in the blood of most
rheumatoid arthritis patients. (An antibody is a special
protein made by the immune system that normally helps
fight foreign substances in the body.) Not all people
with rheumatoid arthritis test positive for rheumatoid
factor, however, especially early in the disease. And,
some others who do test positive never develop the
disease. Other common tests include one that indicates
the presence of inflammation in the body (the erythrocyte
sedimentation rate), a white blood cell count, and a
blood test for anemia.
X rays: X
rays are used to determine the degree of joint
destruction. They are not useful in the early stages of
rheumatoid arthritis before bone damage is evident, but
they can be used later to monitor the progression of the
disease.
TREATMENT
Doctors use a variety of approaches to treat rheumatoid
arthritis. These are used in different combinations and
at different times during the course of the disease and
are chosen according to the patient's individual
situation. No matter what treatment the doctor and
patient choose, however, the goals are the same: relieve
pain, reduce inflammation, slow down or stop joint
damage, and improve the person's sense of well-being and
ability to function.
Treatment is another key
area for communication between patient and doctor.
Talking to the doctor can help ensure that exercise and
pain management programs are provided as needed and that
drugs are prescribed appropriately. Talking can also help
in making decisions about surgery.
Goals of
Treatment
- Relieve pain
- Reduce
inflammation
- Slow down or
stop joint damage
- Slow down or
stop joint damage
- Improve a
person's sense of well-being and ability
to function
Current
Treatment Approaches
- Lifestyle
- Medications
- Surgery
- Routine
monitoring and ongoing care
|
Lifestyle
This approach includes several activities that help
improve a person's ability to function independently and
maintain a positive outlook.
Rest and exercise:
Both rest and exercise help in important ways. People
with rheumatoid arthritis need a good balance between the
two, with more rest when the disease is active and more
exercise when it is not. Rest helps to reduce active
joint inflammation and pain and to fight fatigue. The
length of time needed for rest will vary from person to
person, but in general, shorter rest breaks every now and
then are more helpful than long times spent in bed.
Exercise is important for
maintaining healthy and strong muscles, preserving joint
mobility, and maintaining flexibility. Exercise can also
help people sleep well, reduce pain, maintain a positive
attitude, and lose weight. Exercise programs should be
planned and carried out to take into account the person's
physical abilities, limitations, and changing needs.
Care of joints:
Some people find that using a splint for a short time
around a painful joint reduces pain and swelling by
supporting the joint and letting it rest. Splints are
used mostly on wrists and hands, but also on ankles and
feet. A doctor or a physical or occupational therapist
can help a patient get a splint and ensure that it fits
properly. Other ways to reduce stress on joints include
self-help devices (for example, zipper pullers,
long-handled shoe horns); devices to help with getting on
and off chairs, toilet seats, and beds; and changes in
the ways that a person carries out daily activities.
Stress reduction: People
with rheumatoid arthritis face emotional challenges as
well as physical ones. The emotions they feel because of
the disease-fear, anger, frustration-combined with any
pain and physical limitations can increase their stress
level. Although there is no evidence that stress plays a
role in causing rheumatoid arthritis, it can make living
with the disease difficult at times. Stress may also
affect the amount of pain a person feels. There are a
number of successful techniques for coping with stress.
Regular rest periods can help, as can relaxation,
distraction, or visualization exercises. Exercise
programs, participation in support groups, and good
communication with the health care team are other ways to
reduce stress.
Healthful diet: With
the exception of several specific types of oils
(mentioned in the Current Research section), there is no
scientific evidence that any specific food or nutrient
helps or harms most people with rheumatoid arthritis.
However, an overall nutritious diet with enough-but not
an excess of-calories, protein, and calcium is important.
Some people may need to be careful about drinking
alcoholic beverages because of the medications they take
for rheumatoid arthritis. Those taking methotrexate may
need to avoid alcohol altogether. Patients should ask
their doctors for guidance on this issue.
Climate:
Some people notice that their arthritis gets worse when
there is a sudden change in the weather. However, there
is no evidence that a specific climate can prevent or
reduce the effects of rheumatoid arthritis. Moving to a
new place with a different climate usually does not make
a long-term difference in a person's rheumatoid
arthritis.
Medications
Most people who have rheumatoid arthritis take
medications. Some medications are used only for pain
relief; others are used to reduce inflammation. Still
others-often called disease-modifying antirheumatic
drugs, or DMARDs-are used to try to slow the course of
the disease. The person's general condition, the current
and predicted severity of the illness, the length of time
he or she will take the drug, and the drug's
effectiveness and potential side effects are important
considerations in prescribing drugs for rheumatoid
arthritis. The table starting on page 20 shows currently
used rheumatoid arthritis medications, along with their
effects, side effects, and monitoring requirements.
Traditionally, rheumatoid
arthritis therapy has involved an approach in which
doctors prescribed aspirin or similar drugs, rest, and
physical therapy first, and prescribed more powerful
drugs later only if the disease became much worse.
Recently, many doctors have changed their approach,
especially for patients with severe, rapidly progressing
rheumatoid arthritis. This change is based on the belief
that early treatment with more powerful drugs, and the
use of drug combinations in place of single drugs, may be
more effective ways to halt the progression of the
disease and reduce or prevent joint damage.
Surgery
Several types of surgery are available to patients with
severe joint damage. These procedures can help reduce
pain, improve the affected joint's function and
appearance, and improve the patient's ability to perform
daily activities. Surgery is not for everyone, however,
and the decision should be made only after careful
consideration by patient and doctor. Together they should
discuss the patient's overall health and the effects of a
surgical procedure, the condition of the joint or tendon
that will be operated on, and the reason for and cost of
the surgery. Surgical procedures include joint
replacement, tendon reconstruction, and synovectomy.
Joint
replacement: This is the most frequently
performed surgery for rheumatoid arthritis, and it is
done to relieve pain, improve or preserve joint function,
and improve appearance. In making a decision about
replacing a joint, people with rheumatoid arthritis
should consider that some artificial joints function more
like normal human joints than do others. Also, artificial
joints are not always permanent and may eventually have
to be replaced. This may be an issue for younger people.
Tendon
reconstruction: Rheumatoid arthritis can
damage and even rupture tendons, the tissues that attach
muscle to bone. This surgery, which is used most
frequently on the hands, reconstructs the damaged tendon
by attaching an intact tendon to it. This procedure can
help to restore some hand function, particularly if it is
done early, before the tendon is completely ruptured.
Synovectomy:
In this surgery, the doctor actually removes the inflamed
synovial tissue. Synovectomy by itself is seldom
performed now because not all of the tissue can be
removed, and it eventually grows back. Synovectomy is
done as part of reconstructive surgery, especially tendon
reconstruction.
Routine Monitoring
and Ongoing Care
Regular medical care is important to monitor the course
of the disease, determine the effectiveness and any
negative effects of medications, and change therapies as
needed. Monitoring typically includes regular visits to
the doctor. It may also include blood, urine, and other
laboratory tests and x rays.
Osteoporosis prevention is
one issue that patients may want to discuss with their
doctors as part of their long-term, ongoing care.
Osteoporosis is a condition in which bones lose calcium
and become weakened and fragile. Many older women are at
increased risk for osteoporosis, and their rheumatoid
arthritis increases the risk further, particularly if
they are taking corticosteroids such as prednisone. These
patients may want to discuss with their doctors the
potential benefits of calcium and vitamin D supplements,
hormone replacement therapy, or other treatments for
osteoporosis.
Alternative and
Complementary Therapies
Special diets, vitamin supplements, and other alternative
approaches have been suggested for the treatment of
rheumatoid arthritis. Although many of these approaches
may not be harmful in and of themselves, controlled
scientific studies either have not been conducted or have
found no definite benefit to these therapies. Some
alternative or complementary approaches may help the
patient cope or reduce some of the stress associated with
living with a chronic illness. As with any therapy,
patients should discuss the benefits and drawbacks with
their doctors before beginning an alternative or new type
of therapy. If the doctor feels the approach has value
and will not be harmful, it can be incorporated into a
patient's treatment plan. However, it is important not to
neglect regular health care. The Arthritis Foundation
publishes material on alternative therapies as well as
established therapies, and patients may want to contact
this organization for information. (See the For More
Information section of this booklet.)
Medications
Commonly Used To Treat Rheumatoid Arthritis
Medications
|
Uses/Effects
|
Side Effects
|
Monitoring
|
| Aspirin and other
nonsteroidal anti-inflammatory drugs (NSAIDs) Examples:
Plain aspirin
Buffered
aspirin
Ibuprofen
(Advil,* Motrin IB)
Ketoprofen
(Orudis)
Naproxen
(Naprosyn)
Diclofenac
(Voltaren)
Diflunisal
(Dolobid)
|
Used to reduce pain, swelling, and inflammation,
allowing patients to move more easily and carry
out normal activities Generally part of early and
continuing therapy
|
Upset stomach Tendency to bruise easily
Fluid retention
(NSAIDs other than aspirin)
Ulcers
Possible kidney
and liver damage (rare)
|
Patients
should have periodic blood tests. |
Medications |
Uses/Effects |
Side Effects |
Monitoring |
Disease-modifying anti-rheumatic
drugs (DMARDs)
(also called slow-acting antirheumatic drugs
[SAARDs] or second-line drugs)Examples:
Gold,
injectable or oral (Myochrysine, Ridaura)
Antimalarials,
such as hydroxychloroquine (Plaquenil)
Penicillamine
(Cuprimine, Depen)
Sulfasalazine
(Azulfidine)
|
Used to alter the course of the disease and
prevent joint and cartilage destruction May produce significant
improvement for many patients
Exactly how
they work still unknown
Generally take
a few weeks or months to have an effect
Patients may
use several over the course of the disease
|
Toxicity
is an issue DMARDs can have serious side
effects:
Goldskin rash, mouth sores, upset stomach,
kidney problems, low blood count
Antimalarials
upset stomach, eye problems (rare)
Penicillamineskin rashes, upset stomach, blood
abnormalities, kidney problems
Sulfasalazine
upset stomach
|
Patients
should be monitored carefully for continued
effectiveness
of medication and for side effects: Goldblood and urine
test monthly; more often in early use of drug
Antimalarials
eye exam every 6 months
Penicillamine
blood and urine test monthly; more often in early
use of drug
Sulfasalazine
periodic blood and urine tests
|
Medications |
Uses/Effects |
Side Effects |
Monitoring |
Immuno-
suppressants
(also considered DMARDs)Examples:
Methotrexate
(Rheumatrex)
Azathioprine
(Imuran)
Cyclo-
phosphamide (Cytoxan)
|
Used to restrain the overly active immune system,
which is key to the disease process Same concerns as with
other DMARDs:
potential toxicity and diminishing effectiveness
over time
Methotrexate
can result in rapid improvement; appears to be
very effective
Azathioprine
first used in higher doses
in cancer chemo- therapy and organ
transplantation; used in patients who have not
responded to other drugs; used in combination
therapy
Cyclo-
phosphamide
also used in higher doses in cancer chemotherapy;
effective, but used only in very severe cases of
rheumatoid arthritis because of potential
toxicity
|
Toxicity
is an issue immunosuppressants can have serious
side effects: Methotrexate
upset stomach, potential liver problems, low
white blood cell count
Azathioprine
potential blood abnormalities, low white blood
cell count, possible increased cancer risk
Cyclophosphamide
low white blood cell count, other blood
abnormalities, increased cancer risk
|
Patients
should be monitored carefully for continued
effectiveness
of medication and for side effects: Methotrexate
regular blood tests, including liver function
test; baseline chest x ray
Azathioprine
regular blood and liver function tests
Cyclophosphamide
regular blood, urine, and general medical tests
|
Medications |
Uses/Effects |
Side Effects |
Monitoring |
Corticosteroids
(also known as glucocorticoids)Examples:
Prednisone
(Deltasone, Orasone)
Methylprednisolone
(Medrol)
|
Used for their anti-inflammatory and immuno-
suppressive
effects
Given either in pill form or as an injection into
a joint
Dramatic
improvements in very short time
Potential for
serious side effects, especially at high doses
Often used
early while waiting for DMARDs to work
Also used for
severe flares and when the disease does not
respond to NSAIDs
and DMARDs
|
Osteoporosis
Mood changes
Fragile skin,
easy bruising
Fluid retention
Weight gain
Muscle weakness
Onset or
worsening of diabetes
Cataracts
Increased risk
of infection
Hypertension
(high blood pressure)
|
Patients
should be monitored carefully for continued
effectiveness of medication and for side effects. |
* Brand names included in
this fact sheet are provided as examples only and their
inclusion does not mean that these products are endorsed
by the National Institutes of Health or any other
Government agency. Also, if a particular brand name is
not mentioned, this does not mean or imply that the
product is unsatisfactory.
Current Research
Over the last several decades, research has greatly
increased our understanding of immunology, genetics, and
cellular and molecular biology. This foundation in basic
science is now showing results in several areas important
to rheumatoid arthritis. Scientists are thinking about
rheumatoid arthritis in exciting ways that were not
possible even 10 years ago.
The National Institutes of
Health funds a wide variety of medical research at its
headquarters in Bethesda, Maryland, and at universities
and medical centers across the United States. One of the
NIH institutes, the National Institute of Arthritis and
Musculoskeletal and Skin Diseases, is a major supporter
of research and research training in rheumatoid arthritis
through grants to individual scientists, Specialized
Centers of Research, and Multipurpose Arthritis and
Musculoskeletal Diseases Centers.
Following are examples of
current research directions in rheumatoid arthritis
supported by the Federal Government through the NIAMS and
other parts of the NIH.
Scientists are looking at
basic abnormalities in the immune systems of people with
rheumatoid arthritis and in some animal models of the
disease to understand why and how the disease develops.
Findings from these studies may lead to precise, targeted
therapies that could stop the inflammatory process in its
earliest stages. They may even lead to a vaccine that
could prevent rheumatoid arthritis.
Researchers are studying
genetic factors that predispose some people to developing
rheumatoid arthritis, as well as factors connected with
disease severity. Findings from these studies should
increase our understanding of the disease and will help
develop new therapies as well as guide treatment
decisions. In a major effort aimed at identifying genes
involved in rheumatoid arthritis, the NIH and the
Arthritis Foundation have joined together to support the
North American Rheumatoid Arthritis Consortium. This
group of 12 research centers around the United States is
collecting medical information and genetic material from
1,000 families in which two or more siblings have
rheumatoid arthritis. It will serve as a national
resource for genetic studies of this disease.
Scientists are also
gaining insights into the genetic basis of rheumatoid
arthritis by studying rats with autoimmune inflammatory
arthritis that resembles human disease. NIAMS researchers
have identified several genetic regions that affect
arthritis susceptibility and severity in these animal
models of the disease, and found some striking
similarities between rats and humans. Identifying disease
genes in rats should provide important new information
that may yield clues to the causes of rheumatoid
arthritis in humans.
Scientists are studying
the complex relationships among the hormonal, nervous,
and immune systems in rheumatoid arthritis. For example,
they are exploring whether and how the normal changes in
the levels of steroid hormones (such as estrogen and
testosterone) during a person's lifetime may be related
to the development, improvement, or flares of the
disease. Scientists are also looking at how these systems
interact with environmental and genetic factors. Results
from these studies may suggest new treatment strategies.
Researchers are exploring
why so many more women than men develop rheumatoid
arthritis. In hopes of finding clues, they are studying
female and male hormones and other elements that differ
between women and men, such as possible differences in
their immune responses.
To find clues to new
treatments, researchers are examining why rheumatoid
arthritis often improves during pregnancy. Results of one
study suggest that the explanation may be related to
differences in certain special proteins between a mother
and her unborn child. These proteins help the immune
system distinguish between the body's own cells and
foreign cells. Such differences, the scientists
speculate, may change the activity of the mother's immune
system during pregnancy.
A growing body of evidence
indicates that infectious agents, such as viruses and
bacteria, may trigger rheumatoid arthritis in people who
have an inherited predisposition to the disease.
Investigators are trying to discover which infectious
agents may be responsible. More broadly, they are also
working to understand the basic mechanisms by which these
agents might trigger the development of rheumatoid
arthritis. Identifying the agents and understanding how
they work could lead to new therapies.
Scientists are searching
for new drugs or combinations of drugs that can reduce
inflammation, can slow or stop the progression of
rheumatoid arthritis, and also have few side effects.
Studies in humans have shown that a number of compounds
have such potential. For example, some studies are
breaking new ground in the area of
"biopharmaceuticals," or "biologics."
These new drugs are based on compounds occurring
naturally in the body, and are designed to target
specific aspects of the inflammatory process.
Investigators have also
shown that treatment of rheumatoid arthritis with
minocycline, a drug in the tetracycline family, has a
modest benefit. The effects of a related tetracycline
called doxycycline are under investigation. Other studies
have shown that the omega-3 fatty acids in certain fish
or plant seed oils also may reduce rheumatoid arthritis
inflammation. However, many peoet is
also available 24 hours a day by fax. Using the phone on
a fax machine, call NIAMS Fast Facts at (301) 881-2731.
Listen to the instructions and dial 01301; the text will
print to the fax machine.
The National Arthritis and
Musculoskeletal and Skin Diseases Information
Clearinghouse (NAMSIC) is a public service sponsored by
the NIAMS that provides health information and
information sources. The Clearinghouse provides
information on rheumatoid arthritis, including a fact
sheet on arthritis and exercise. Fact sheets, additional
information, and research updates can also be found on
the NIAMS Web site at http://www.nih.gov/niams/.
Arthritis Foundation
1330 West Peachtree Street
Atlanta, GA 30309
(800) 283-7800
(404) 872-7100
or your local chapter,
listed in the telephone directory
Web address:
http://www.arthritis.org
The Arthritis Foundation
is the major voluntary organization devoted to supporting
arthritis research and providing educational and other
services to individuals with arthritis. The foundation
publishes a free pamphlet on rheumatoid arthritis and a
magazine for members on all types of arthritis. It also
provides up-to-date information on research and
treatment, nutrition, alternative therapies, and
self-management strategies. Chapters nationwide offer
exercise programs, classes, support groups, physician
referral services, and free literature.
Acknowledgments
The NIAMS gratefully acknowledges the assistance of the
following people in the preparation and review of this
publication: John H. Klippel, M.D., NIAMS, NIH; Reva
Lawrence, M.P.H., NIAMS, NIH; Amye L. Leong, San Pedro
Peninsula, California; Michael D. Lockshin, M.D., Barbara
Volcker Center for Women and Rheumatic Disease, Hospital
for Special Surgery, New York, New York; Kate Lorig,
R.N., Dr.P.H., Stanford University, Stanford, California;
J. Lee Nelson, M.D., Fred Hutchinson Cancer Research
Center, Seattle, Washington; Stanley R. Pillemer, M.D.,
NIH; Paul H. Plotz, M.D., NIAMS, NIH; Paul G. Rochmis,
M.D., Fairfax Virginia; and Ronald L. Wilder, M.D.,
Ph.D., NIAMS, NIH. Special thanks also go to Cheryl
Yarboro, R.N., B.S.P.A., NIAMS, NIH, and to the patients
who reviewed this publication and provided valuable
input. This booklet was written by Anne Brown Rodgers of
Cygnus Corporation.
About NIAMS and
NAMSIC
The National Arthritis and Musculoskeletal and Skin
Diseases Information Clearinghouse (NAMSIC) is a public
service sponsored by the NIAMS that provides health
information and information sources. The NIAMS, a part of
the National Institutes of Health (NIH), leads the
Federal medical research effort in arthritis and
musculoskeletal and skin diseases. The NIAMS supports
research and research training throughout the United
States as well as on the NIH campus in Bethesda,
Maryland, and disseminates health and research
information. Additional information and research updates
can be found on the NIAMS Web site at
http://www.nih.gov/niams/
|